Infections after anti-CD19 chimeric antigen receptor T-cell therapy for hematologic malignancies: timeline, prevention, and uncertainties

MLA

Will Garner, et al. “Infections after Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies: Timeline, Prevention, and Uncertainties.” Current Opinion in Infectious Diseases, vol. 33, no. 6, Oct. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8a94d836370391c4de4dfaafb920d8a7&authtype=sso&custid=ns315887.

APA

Will Garner, Ghady Haidar, & Joshua A. Hill. (2020). Infections after anti-CD19 chimeric antigen receptor T-cell therapy for hematologic malignancies: timeline, prevention, and uncertainties. Current Opinion in Infectious Diseases, 33(6).

Chicago

Will Garner, Ghady Haidar, and Joshua A. Hill. 2020. “Infections after Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies: Timeline, Prevention, and Uncertainties.” Current Opinion in Infectious Diseases 33 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8a94d836370391c4de4dfaafb920d8a7&authtype=sso&custid=ns315887.